Xenon Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The ESG rating for Xenon Pharmaceuticals Inc represents its transparency towards the United Nations SDGs. If you are employed by Xenon Pharmaceuticals Inc and you would like to licence your Sustainability aseessment, please contact us. The page contains a zero-cost ESG report covering Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 4.0, social score of 3.2 and governance score of 4.8.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
| 989 | Tricida Inc | 4.1 | High |
| 1004 | Xenon Pharmaceuticals Inc | 4.0 | High |
| 1004 | Can B Corp | 4.0 | High |
| 1004 | CLS Holdings USA Inc | 4.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Xenon Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Xenon Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Xenon Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Xenon Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Xenon Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Xenon Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Xenon Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.